Evaluation of Iopofosine I 131 vs. R-CD in WM Patients

Clinical trial NCT07766421 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07766421
Sponsor: Cellectar Biosciences, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Waldenstrom Macroglobulinaemia Waldenstrom Macroglobulinemia Waldenstrom's Macroglobulinaemia Refractory Waldenstrom Macroglobulinemia With Nodal Disease Waldenstrom's Macroglobulinemia Recurrent

Start date: 2026-12-01
Primary completion: 2032-01-01
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.